Kei Muro

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Topics

Body Composition

Squamous Cell Carcinoma

Metastatic Colorectal Cancer

Neoadjuvant Chemotherapy

Top Venues

Cancer medicine

Journal of clinical medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Takayama Koichi, Ai Kojima, Chikara Honda, Masahiro Nakayama, Satomi Kanemata, Toshimitsu Endo, Kei Muro
Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan. Cancer medicine 13 (9) (2024)
Takayama Koichi, Ai Kojima, Chikara Honda, Masahiro Nakayama, Satomi Kanemata, Toshimitsu Endo, Kei Muro
Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan. Cancer medicine 13 (9) (2024)
Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto, Hiasto Kawakami, Takashi Oshima, Kensei Yamaguchi, Kaori Hino, Motohiro Hirao, Yukinori Kurokawa, Takeshi Kawakami, Masahiro Tsuda, Hiroki Hara, Shota Kaname, Daiko Matsuoka, Yohei Otake, Keisuke Yasuda, Takao Takase, Shuya Takashima, Taro Semba, Kei Muro
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto, Hiasto Kawakami, Takashi Oshima, Kensei Yamaguchi, Kaori Hino, Motohiro Hirao, Yukinori Kurokawa, Takeshi Kawakami, Masahiro Tsuda, Hiroki Hara, Shota Kaname, Daiko Matsuoka, Yohei Otake, Keisuke Yasuda, Takao Takase, Shuya Takashima, Taro Semba, Kei Muro
Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Takayama Koichi, Ai Kojima, Chikara Honda, Masahiro Nakayama, Satomi Kanemata, Toshimitsu Endo, Kei Muro
Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan. Cancer medicine 13 (9) (2024)
Takayama Koichi, Ai Kojima, Chikara Honda, Masahiro Nakayama, Satomi Kanemata, Toshimitsu Endo, Kei Muro
Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan. Cancer medicine 13 (9) (2024)
Yukiya Narita, Kei Muro
Updated Immunotherapy for Gastric Cancer. Journal of clinical medicine 12 (7) (2023)
Nobuhito Ito, Masahiro Tajika, Tsutomu Tanaka, Keisaku Yamada, Akihiro Takagi, Sachiyo Onishi, Tetsuya Abe, Eiji Higaki, Hironori Fujieda, Yoshitaka Inaba, Kei Muro, Hiroki Kawashima, Yasumasa Niwa
Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer. Journal of clinical medicine 12 (21) (2023)
Chiaki Inagaki, Ryo Matoba, Satoshi Yuki, Manabu Shiozawa, Akihito Tsuji, Eisuke Inoue, Kei Muro, Wataru Ichikawa, Masashi Fujii, Yu Sunakawa
The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF -mutated metastatic colorectal cancer. Future oncology (London, England) 19 (17) (2023)
Fortunato Ciardiello, Yung-Jue Bang, Andrés Cervantes, Mikhail Dvorkin, Charles D Lopez, Jean-Philippe Metges, Antonio Sánchez Ruiz, Mariona Calvo, Andrew H Strickland, George Kannourakis, Kei Muro, Hiasto Kawakami, Jia Wei, Christophe Borg, Zhaoyin Zhu, Neal Gupta, Robert J Pelham, Lin Shen
Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results. Cancer medicine (2023)
Takeshi Kawakami, Toshiki Masuishi, Yasuyuki Kawamoto, Hirofumi Go, Kyoko Kato, Ryosuke Kumanishi, Kentaro Sawada, Satoshi Yuki, Kouji Yamamoto, Yoshito Komatsu, Kei Muro, Kunihiro Fushiki, Hiromichi Shirasu, Kentaro Yamazaki
The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study. Cancer medicine 11 (11) (2022)
Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, Keisaku Yamada, Tomoyasu Kamiya, Tetsuya Abe, Eiji Higaki, Hironori Fujieda, Takuya Nagao, Yoshitaka Inaba, Kei Muro, Masahito Shimizu, Yasumasa Niwa
Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Journal of clinical medicine 11 (3) (2022)
Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily Brooks, Bo Xu, Wei Li, Chiang J Li, Laura Borodyansky, Eric Van Cutsem
Randomized, double-blind, placebo-controlled phase 3 study of paclitaxel {plus minus} napabucasin in pretreated advanced gastric or gastroesophageal junction adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Takao Takahashi, Kazuyuki Ishida, Yasunori Emi, Michiie Sakamoto, Johji Imura, Shinichi Aishima, Kei Muro, Hiroyuki Uetake, Eiji Oki, Yu Katayose, Kazuhiro Yoshida, Michiaki Unno, Ichinosuke Hyodo, Naohiro Tomita, Kenichi Sugihara, Yoshihiko Maehara
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial. Cancers 14 (18) (2022)
Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays, Naureen Starling, Rui-Hua Xu, Keren Sturtz, Marilyn Fontaine, Cindy Oh, Emily M Brooks, Bo Xu, Wei Li, Chiang J Li, Laura Borodyansky, Eric Van Cutsem
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Tateaki Naito, Uchino Junji, Toru Kojima, Yutaka Matano, Koichi Minato, Kentaro Tanaka, Takuro Mizukami, Shinji Atagi, Takashi Higashiguchi, Kei Muro, Takayama Koichi, Junji Furuse, Eiichiro Morishima, Toru Takiguchi, Kazuo Tamura
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index. Cancer 128 (10) (2022)
Kei Muro, Takashi Kojima, Toshikazu Moriwaki, Ken Kato, Fumio Nagashima, Hisato Kawakami, Ryu Ishihara, Takashi Ogata, Taroh Satoh, Keiichi Iwakami, Shirong Han, Naoyoshi Yatsuzuka, Tomoko Takami, Pooja Bhagia, Toshihiko Doi
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181. Esophagus : official journal of the Japan Esophageal Society (2021)
Takuro Mizukami, Tempei Miyaji, Yukiya Narita, Tomohiro Matsushima, Takashi Ogura, Hiromichi Miyagaki, Ryohei Kawabata, Yoshiki Horie, Takashi Kawaguchi, Kei Muro, Hiroki Hara, Takuhiro Yamaguchi, Takako Eguchi Nakajima
An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study. Future oncology (London, England) 17 (19) (2021)
Hiasto Kawakami, Shuichi Hironaka, Taito Esaki, Kazuaki Chayama, Masahiro Tsuda, Naotoshi Sugimoto, Shigenori Kadowaki, Akitaka Makiyama, Nozomu Machida, Hidekazu Hirano, Kenro Hirata, Hiroki Hara, Hiroshi Yabusaki, Yoshito Komatsu, Kei Muro
An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7). Cancers 13 (4) (2021)
Hiroyuki Arai, Eisuke Inoue, Kensei Yamaguchi, Narikazu Boku, Hiroki Hara, Tomohiro Nishina, Masahiro Tsuda, Kohei Shitara, Katsunori Shinozaki, Shinichiro Nakamura, Ichinosuke Hyodo, Kei Muro, Mitsuru Sasako, Masanori Terashima, Takako E Nakajima
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G. Cancer medicine 10 (21) (2021)
Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, Keisaku Yamada, Tetsuya Abe, Eiji Higaki, Takahiro Hosoi, Yoshitaka Inaba, Kei Muro, Masahito Shimizu, Yasumasa Niwa
Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma. Journal of clinical medicine 9 (9) (2020)
Kensei Yamaguchi, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Yoshito Komatsu, Tomohiro Nishina, Yasushi Omuro, Takao Tamura, Yongzhe Piao, Gosuke Homma, Min-Hua Jen, Astra M Liepa, Kei Muro
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial. Clinical drug investigation 41 (1) (2020)
Kei Muro, Taylor Salinardi, Arvind Rup Singh, Teresa Macarulla
Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data. Cancers 12 (4) (2020)
Stefano Cascinu, György Bodoky, Kei Muro, Eric Van Cutsem, Sang Cheul Oh, Gunnar Folprecht, Sumitra Ananda, Gustavo Girotto, Zev A Wainberg, Maria Luisa Limon Miron, Jaffer A Ajani, Ran Wei, Astra M Liepa, Roberto Carlesi, Michael Emig, Atsushi Ohtsu
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer. The oncologist 26 (3) (2020)